Cerebral Ischemia: Clinical Trials

4 trials for Cerebral Ischemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Recruiting 1

Follow Cerebral Ischemia: new trials by email Literature Review of Cerebral Ischemia trials Research Report on Cerebral Ischemia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
Xenon, air/oxygen - Subarachnoid Hemorrhage, Aneurysmal, Cerebral Injury
Phase 2RecruitingTurku University Hospital1602025-04-222025-05-01
PMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients
Normal Saline along with standard treatment, PMZ-1620 along with standard treatment - Acute Stroke, Cerebral Ischemia
Phase 2CompletedPharmazz, Inc.402018-01-192025-05-12
Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke
Argatroban - Stroke, Cerebral Ischemia
Phase 2CompletedThe University of Texas Health Science Center, Houston102015-05-012017-06-21
Safety and Effect of SANGUINATEā„¢ Infusion in Patients at Risk of Delayed Cerebral Ischemia (DCI) Following Subarachnoid Hemorrhage (SAH)
SANGUINATEā„¢ - Cerebral Ischemia
Phase 2CompletedProlong Pharmaceuticals122014-12-012016-10-27

Narrower conditions

Brain Ischemia (4)  ·  Stroke (2)  ·  Subarachnoid Hemorrhage (2)  ·  Brain Injuries (1)  ·  Cardiovascular Diseases (1)  ·  Cerebral Infarction (1)  ·  Heart Failure (1)

Broader conditions

Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Cerebrovascular Disorders (4)  ·  Nervous System Diseases (4)  ·  Vascular Diseases (4)  ·  Cardiovascular Diseases (3)  ·  Hemorrhage (2)  ·  Intracranial Hemorrhages (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Brain Infarction (1)  ·  Craniocerebral Trauma (1)  ·  Heart Diseases (1)  ·  Infarction (1)  ·  Ischemia (1)

Interventions

PEGylated carboxyhemoglobin bovine (1)  ·  Xenon (1)  ·  argatroban (1)  ·  sovateltide (1)

Sponsors

Pharmazz, Inc. (1)  ·  Prolong Pharmaceuticals (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  Turku University Hospital (1)

Countries

United States (2)  ·  Finland (1)  ·  India (1)  ·  Sweden (1)

Top investigators

Andrew D Barreto, MD, MS (1)  ·  Anil Gulati (1)  ·  Michael N Dirringer, MD (1)  ·  Rajat Dhar, MD (1)  ·  Timo T Laitio, MD, PhD (1)

Results publications

PMID 26978207, PMID 29169472, PMID 33428177, PMID 37337295

NIH funding

2019 (1)